Is portable MRI suitable for finding abnormalities in the brains of patients receiving new amyloid-targeting therapy for Alzheimer’s disease? Clinical researchers are about to find out.
There were no statistical differences in overall complication rates between the traditional and expedited groups, but there were marked savings and shorter hospital stays.
In the years since the turn of the century, interventional radiology has made quantifiable strides toward familiarizing the general public with the specialty and, along the way, helping IR better compete for business with surgery.
In a study of more than 250 COVID-positive patients with a history of any cancer, fewer than half the cohort had chest CT findings deemed typical for COVID-related pneumonia based on an RSNA classification guide.
The model augmented and significantly improved diagnostic performance for abdominal subspecialists as well as residents—a result researchers say has major clinical implications.
A multidisciplinary center dedicated to early detection of cancer in ostensibly healthy individuals has demonstrated the soundness of its founding concept, cost-effectively catching cancers of many kinds before the onset of symptoms.
The FDA has declined to accelerate approval of Eli Lilly’s highly anticipated Alzheimer’s drug, but the reason for the rejection may presage a forthcoming thumbs-up.
"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.
